Intention to float
Abcam plc, a profitable, rapidly growing company which sells antibodies, announces its intention to join the AIM market of the London Stock Exchange by way of a placing through Numis Securities.
Abcam plans to raise up to approximately £10 million, before expenses, by way of a placing of new ordinary shares with institutional and other investors.
It is anticipated that Abcam shares will begin trading on AIM in November 2005.
For more information, please contact Buchanan Communications.
back to news list